Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Juva Life Inc. JUVAF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
20/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Juva Life Inc. (JUVAF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 19/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $6M, +173.3%/yr average growth. Net income is $10M (loss), growing at -14.4%/yr. Net profit margin is -181.9% (negative). Gross margin is 0.8% (-43.5 pp trend).

Balance sheet: total debt is $8M against $10M equity (Debt-to-Equity (D/E) ratio 0.82, moderate). Current ratio is 1.11 (adequate). Debt-to-assets is 39.4%. Total assets: $20M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 33/100 (Fail), Moat 0/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

JUVAF SharesGrow Score Overview

34/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — JUVAF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
JUVAF: +173.3%/yr revenue is, -14.4%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet JUVAF: Debt-to-Equity (D/E) ratio 0.82 (moderate), Current ratio is 1.11 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
JUVAF: Net profit margin is -181.9%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.00001-0.0012
Volume100
Avg Volume (30D)3.07K
Market Cap$1.64K
Beta (1Y)0.62
Share Statistics
EPS (TTM)-0.06
Shares Outstanding$164.03M
IPO Date2021-01-08
CEOMathew Lee
Financial Highlights & Ratios
Revenue (TTM)$5.76M
Gross Profit$43.97K
EBITDA$-6.84M
Net Income$-10.48M
Operating Income$-8.12M
Total Cash$641.04K
Total Debt$8.02M
Net Debt$7.38M
Total Assets$20.37M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA48222R1010

Price Chart

Track all markets on TradingView
JUVAF
Juva Life Inc. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.00

People Also View

RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 PHCG
PHCG
Pure Harvest Corporate Group, Inc.
$0.01
+4.00%
 CVGRF
CVGRF
City View Green Holdings Inc.
$0.03
-4.57%
 SPBBF
SPBBF
Speakeasy Cannabis Club Ltd.
$0.00
+0.00%
 RVVQF
RVVQF
RavenQuest BioMed Inc.
$0.00
+0.00%
 BHHKF
BHHKF
Craftport Cannabis Corp.
$0.00
+0.00%
 CRFTF
CRFTF
BC Craft Supply Co. Ltd.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message